XML 169 R150.htm IDEA: XBRL DOCUMENT v3.24.0.1

SEGMENT INFORMATION - Financial Information of Segments (Details) - USD ($) $ in Millions	3 Months Ended								6 Months Ended	12 Months Ended
	Dec. 31, 2023	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2023	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Segment Reporting Information [Line Items]
Net sales	$ 3,885	$ 3,708	$ 3,707	$ 3,513	$ 3,745	$ 3,609	$ 3,594	$ 3,558		$ 14,813	$ 14,506	$ 12,146
United States
Segment Reporting Information [Line Items]
Net sales										7,000	6,955	4,938
Non-US
Segment Reporting Information [Line Items]
Net sales										7,813	7,551	7,208
Other | Revision of Prior Period, Adjustment
Segment Reporting Information [Line Items]
Net sales				2							37	31
BPS | Revision of Prior Period, Adjustment
Segment Reporting Information [Line Items]
Net sales				$ (2)							(37)	(31)
Operating Segments | Medical Products and Therapies
Segment Reporting Information [Line Items]
Net sales										5,011	4,815	4,821
Operating Segments | Healthcare Systems and Technologies
Segment Reporting Information [Line Items]
Net sales										3,013	2,939	212
Operating Segments | Pharmaceuticals
Segment Reporting Information [Line Items]
Net sales										2,249	2,126	2,291
Operating Segments | Kidney Care
Segment Reporting Information [Line Items]
Net sales										4,453	4,449	4,682
Operating Segments | United States | Medical Products and Therapies
Segment Reporting Information [Line Items]
Net sales										2,809	2,815	2,747
Operating Segments | United States | Healthcare Systems and Technologies
Segment Reporting Information [Line Items]
Net sales										2,168	2,135	149
Operating Segments | United States | Pharmaceuticals
Segment Reporting Information [Line Items]
Net sales										759	682	753
Operating Segments | United States | Kidney Care
Segment Reporting Information [Line Items]
Net sales										1,198	1,186	1,177
Operating Segments | Non-US | Medical Products and Therapies
Segment Reporting Information [Line Items]
Net sales										2,202	2,000	2,074
Operating Segments | Non-US | Healthcare Systems and Technologies
Segment Reporting Information [Line Items]
Net sales										845	804	63
Operating Segments | Non-US | Pharmaceuticals
Segment Reporting Information [Line Items]
Net sales										1,490	1,444	1,538
Operating Segments | Non-US | Kidney Care
Segment Reporting Information [Line Items]
Net sales										3,255	3,263	3,505
Operating Segments | Infusion Therapies and Technologies | Medical Products and Therapies
Segment Reporting Information [Line Items]
Net sales										3,960	3,817	3,844
Operating Segments | Infusion Therapies and Technologies | United States | Medical Products and Therapies
Segment Reporting Information [Line Items]
Net sales										2,227	2,241	2,202
Operating Segments | Infusion Therapies and Technologies | Non-US | Medical Products and Therapies
Segment Reporting Information [Line Items]
Net sales										1,733	1,576	1,642
Operating Segments | Advanced Surgery | Medical Products and Therapies
Segment Reporting Information [Line Items]
Net sales										1,051	998	977
Operating Segments | Advanced Surgery | United States | Medical Products and Therapies
Segment Reporting Information [Line Items]
Net sales										582	574	545
Operating Segments | Advanced Surgery | Non-US | Medical Products and Therapies
Segment Reporting Information [Line Items]
Net sales										469	424	432
Operating Segments | Care and Connectivity Solutions | Healthcare Systems and Technologies
Segment Reporting Information [Line Items]
Net sales										1,800	1,791	142
Operating Segments | Care and Connectivity Solutions | United States | Healthcare Systems and Technologies
Segment Reporting Information [Line Items]
Net sales										1,263	1,295	98
Operating Segments | Care and Connectivity Solutions | Non-US | Healthcare Systems and Technologies
Segment Reporting Information [Line Items]
Net sales										537	496	44
Operating Segments | Front Line Care | Healthcare Systems and Technologies
Segment Reporting Information [Line Items]
Net sales										1,213	1,148	70
Operating Segments | Front Line Care | United States | Healthcare Systems and Technologies
Segment Reporting Information [Line Items]
Net sales										905	840	51
Operating Segments | Front Line Care | Non-US | Healthcare Systems and Technologies
Segment Reporting Information [Line Items]
Net sales										308	308	19
Operating Segments | Injectables and Anesthesia | Pharmaceuticals
Segment Reporting Information [Line Items]
Net sales										1,347	1,305	1,390
Operating Segments | Injectables and Anesthesia | United States | Pharmaceuticals
Segment Reporting Information [Line Items]
Net sales										759	682	753
Operating Segments | Injectables and Anesthesia | Non-US | Pharmaceuticals
Segment Reporting Information [Line Items]
Net sales										588	623	637
Operating Segments | Drug Compounding | Pharmaceuticals
Segment Reporting Information [Line Items]
Net sales										902	821	901
Operating Segments | Drug Compounding | United States | Pharmaceuticals
Segment Reporting Information [Line Items]
Net sales										0	0	0
Operating Segments | Drug Compounding | Non-US | Pharmaceuticals
Segment Reporting Information [Line Items]
Net sales										902	821	901
Operating Segments | Chronic Therapies | Revision of Prior Period, Reclassification, Adjustment
Segment Reporting Information [Line Items]
Net sales									$ (16)		(34)	(38)
Operating Segments | Chronic Therapies | Kidney Care
Segment Reporting Information [Line Items]
Net sales										3,683	3,714	3,862
Operating Segments | Chronic Therapies | United States | Kidney Care
Segment Reporting Information [Line Items]
Net sales										927	923	869
Operating Segments | Chronic Therapies | Non-US | Kidney Care
Segment Reporting Information [Line Items]
Net sales										2,756	2,791	2,993
Operating Segments | Acute Therapies | Revision of Prior Period, Reclassification, Adjustment
Segment Reporting Information [Line Items]
Net sales									$ 16		34	38
Operating Segments | Acute Therapies | Kidney Care
Segment Reporting Information [Line Items]
Net sales										770	735	820
Operating Segments | Acute Therapies | United States | Kidney Care
Segment Reporting Information [Line Items]
Net sales										271	263	308
Operating Segments | Acute Therapies | Non-US | Kidney Care
Segment Reporting Information [Line Items]
Net sales										499	472	512
Other
Segment Reporting Information [Line Items]
Net sales										87	177	140
Other | United States
Segment Reporting Information [Line Items]
Net sales										66	137	112
Other | Non-US
Segment Reporting Information [Line Items]
Net sales										$ 21	$ 40	$ 28

X

- Definition

Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 924
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 11.L)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-5

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 30
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-30

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 42
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-42

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-22

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-32

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 40
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-40

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-22

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-32

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 41
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-41

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-4

+ Details

Name:	us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingInformationLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	srt_StatementGeographicalAxis=country_US
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_StatementGeographicalAxis=us-gaap_NonUsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=bax_OtherMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_RestatementAxis=srt_RestatementAdjustmentMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=bax_BPSMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=bax_MedicalProductsAndTherapiesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=bax_HealthcareSystemsAndTechnologiesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=bax_PharmaceuticalsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=bax_KidneyCareMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=bax_InfusionTherapiesAndTechnologiesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=bax_AdvancedSurgeryMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=bax_CareAndConnectivitySolutionsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=bax_FrontLineCareMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=bax_InjectablesAndAnesthesiaMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=bax_PharmaceuticalCompoundingMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=bax_ChronicRenalMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_RestatementAxis=srt_RevisionOfPriorPeriodReclassificationAdjustmentMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=bax_AcuteTherapiesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: